Panasonic's (PCRFY -3.03%) not the first company you may think of in the health-care field, but this Japanese electronics maker's a player in blood glucose monitors and other fields. With Panasonic's sales under fire across the board, however, this company's looking to sell off its health-care business to refocus on its core segments. Toshiba (TOSBF) reportedly has expressed interest in a buy, and private equity-firms are also in the hunt to get on board with Asia's health-care rise.
Buying into the Asian health-care scene isn't anything new. Stryker (SYK 0.95%) made waves earlier this year by purchasing Chinese spine and trauma firm Trauson for $764 million, and with China's health-care industry still in a state of transition, this is a potent grow opportunity for device firms. But is Panasonic's business worth all that much to buyers? Motley Fool contributor Dan Carroll and health-care analyst Max Macaluso discuss what you need to know in the following video.
